AVALON US TRANSDUCER
Report
- Report Number
- 9610816-2024-00283
- Event Type
- Malfunction
- Date Received
- May 28, 2024
- Date of Event
- November 14, 2023
- Report Date
- August 23, 2024
- Manufacturer
- PHILIPS MEDIZIN SYSTEME BÖBLINGEN GMBH
- Product Code
- HGL
- UDI-DI
- 00884838093195
- PMA / PMN Number
- K140535
- Removal / Correction Number
- Z-2239-2024
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- BIOMEDICAL ENGINEER
- Health Professional
- Yes
Narratives
PHILIPS IS IN THE PROCESS OF OBTAINING ADDITIONAL INFORMATION CONCERNING THIS EVENT AND THE COMPLAINT IS STILL UNDER INVESTIGATION. A FINAL REPORT WILL BE SUBMITTED ONCE THE INVESTIGATION IS COMPLETE.
BASED ON THE INFORMATION AVAILABLE AND THE TESTING CONDUCTED, THE CAUSE OF THE REPORTED PROBLEM WAS A DESIGN DEFECT IN THE TRANSDUCER'S FIRMWARE (FW). PHILIPS INVESTIGATION DETERMINED THIS ISSUE IS CAUSED BY CHANGES IMPLEMENTED UNDER AN ENGINEERING CHANGE RELEASED (B)(6) 2023. THESE CHANGES UPDATED THE ULTRASOUND T=TRANSDUCER WITH A NEW CENTRAL PROCESSING UNIT (CPU) BOARD AND FIRMWARE IN RESPONSE TO A SHORTAGE OF MULTIPLE COMPONENTS. DUE TO A CHIP SHORTAGE SITUATION, A HARDWARE (HW)/SOFTWARE (SW) DESIGN CHANGE WAS REQUIRED, WHICH INTRODUCED A PERFORMANCE ISSUE TO THE FETAL HEART RATE (FHR) MEASUREMENT OF WIRED ULTRASOUND (US) TRANSDUCERS. THE NEED FOR SUBTLE ADJUSTMENTS OF THE TRANSMIT/RECEIVE TIME WINDOWS IN US MEASUREMENTS UNEXPECTEDLY INTRODUCED INTERFERENCE WITH ADJACENT TRANSDUCERS (TWIN/TRIPLET USE CASES) BY GENERATING MEASURABLE ARTIFICIAL RHYTHMIC SIGNALS THAT CAN BE INTERPRETED AS ACTUAL PHYSIOLOGICAL SIGNALS (FETAL HEART BEATS). THIS INVESTIGATION DETERMINED THAT THE NEW FIRMWARE (453564254621-S-FW-01, REV L.01.04) WHICH IS DESIGNED FOR ALL AVALON TRANSDUCERS, SHOWS AN UNEXPECTED ISSUE FOR THE ULTRASOUND TRANSDUCER (867246). WHEN MONITORING MULTIPLES (TWINS OR TRIPLETS), THE WIRED AVALON ULTRASOUND TRANSDUCERS (PRODUCT NO. 867246) HAVE A TENDENCY TO PRODUCE AN ARTIFICIAL FETAL HEART RATE (FHR) INSTEAD OF FHR GAPS, MOSTLY AT APPROXIMATELY 180 BPM, IN SITUATIONS WHERE THE PHYSIOLOGICAL SIGNAL (ECHO FROM PULSATING FETAL HEART) IS ABSENT OR VERY WEAK. A FIELD CHANGE ORDER (FCO) WAS IMPLEMENTED ON (B)(6) 2024 TO UPDATE THE TRANSDUCER FIRMWARE.
THE CUSTOMER REPORTED THAT THE FETAL HEART RATE OBTAINED WITH THE AVALON US TRANSDUCER WITH FIRMWARE REVISION L.01.04 WAS INCORRECT WHEN MEASURING TWINS. THE DEVICE WAS IN USE MONITORING A PATIENT AT THE TIME OF THE REPORTED ISSUE. NO DEATH OR PATIENT INJURY OR HARM WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2321217 | AVALON US TRANSDUCER | AVALON US TRANSDUCER | HGL | PHILIPS MEDIZIN SYSTEME BÖBLINGEN GMBH | 867246 | 00884838093195 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |